Yep possibly the case but maybe different if hadn't failed at...

Yep possibly the case but maybe different if hadn't failed at bat couple times, maybe we'd be in the money but even so imo still 10 years away and in that time will burn through a lot of money with trials and production plus wages that's a shit ton of CR's won't get their imo without a favorable partnership and that means dilution more dilution and yep same again.

If I was to draw some kind of related parallels with another bio I own MSB, that has had knockback after knockback from the FDA due to its suggested failure to prove unequivocally that it can produce a consistent and reliable product then how does that then go for PAB unless of course they can conquer this and get some positive runs on the board for me they are a dodo in waiting.

I think we need to move on they'll remain on the watchlist, but this is why I won't be buying any let's hope they can redeem themselves and become great.

Cheers mate, that's all from me on PAB